Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 126.56 -1.44 (-1.12%)
As of 03/25/2025 12:42 PM Eastern

BBH vs. TFG, LWDB, JMG, ASL, IHP, EDIN, FSV, ASHM, GSS, and BPCR

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Tetragon Financial (TFG), Law Debenture (LWDB), JPMorgan Emerging Markets (JMG), Aberforth Smaller Companies Trust (ASL), IntegraFin (IHP), Edinburgh Investment (EDIN), Fidelity Investment Trust - Fidelity Special Values (FSV), Ashmore Group (ASHM), Genesis Emerging Markets Fund (GSS), and BioPharma Credit (BPCR). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

Tetragon Financial (LON:TFG) and Bellevue Healthcare (LON:BBH) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation.

Bellevue Healthcare received 87 more outperform votes than Tetragon Financial when rated by MarketBeat users. However, 77.42% of users gave Tetragon Financial an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote.

CompanyUnderperformOutperform
Tetragon FinancialOutperform Votes
24
77.42%
Underperform Votes
7
22.58%
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%

Tetragon Financial pays an annual dividend of GBX 44 per share and has a dividend yield of 297.1%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.7%. Tetragon Financial pays out 2,822.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend.

3.2% of Tetragon Financial shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 17.8% of Tetragon Financial shares are owned by insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bellevue Healthcare has a net margin of 169.10% compared to Tetragon Financial's net margin of 57.23%. Tetragon Financial's return on equity of 4.68% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Tetragon Financial57.23% 4.68% 3.14%
Bellevue Healthcare 169.10%-4.48%N/A

Tetragon Financial has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Tetragon Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tetragon Financial£22.12B0.05£12.66B£1.569.50
Bellevue Healthcare-£9.60M-32.51-£16.23M-£6.57-19.25

In the previous week, Bellevue Healthcare had 1 more articles in the media than Tetragon Financial. MarketBeat recorded 2 mentions for Bellevue Healthcare and 1 mentions for Tetragon Financial. Tetragon Financial's average media sentiment score of 0.67 beat Bellevue Healthcare's score of 0.62 indicating that Tetragon Financial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tetragon Financial
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bellevue Healthcare
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Tetragon Financial beats Bellevue Healthcare on 11 of the 16 factors compared between the two stocks.

Remove Ads
Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£311.93M£1.17B£4.28B£2.61B
Dividend Yield3.82%4.41%4.18%4.95%
P/E Ratio-19.2527.0916.01152.77
Price / Sales-32.512,289.551,718.75283,340.74
Price / CashN/A60.8148.9727.97
Price / Book0.841.123.374.61
Net Income-£16.23M£258.33M£1.27B£5.78B
7 Day Performance-0.34%0.17%0.54%-0.25%
1 Month Performance-8.42%-1.64%6.75%4.02%
1 Year Performance-16.07%5.38%11.03%126.57%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 126.57
-1.1%
N/A-15.4%£311.93M£-9,595,061.74-19.25N/AHigh Trading Volume
TFG
Tetragon Financial
N/AGBX 14.96
-0.3%
N/A+51.9%£1.21B£22.12B9.60N/A
LWDB
Law Debenture
N/AGBX 910.88
+0.9%
N/A+14.2%£1.20B£203.87M8.48260News Coverage
Positive News
JMG
JPMorgan Emerging Markets
N/AGBX 107.80
-0.2%
N/A+2.9%£1.14B£97.45M14.28N/AHigh Trading Volume
ASL
Aberforth Smaller Companies Trust
N/AGBX 1,366
+0.1%
N/A+0.3%£1.14B£226.05M4.49N/APositive News
High Trading Volume
IHP
IntegraFin
3.3375 of 5 stars
GBX 334
flat
GBX 413.33
+23.8%
+19.7%£1.11B£138.65M21.183,520Dividend Increase
News Coverage
High Trading Volume
EDIN
Edinburgh Investment
N/AGBX 750.38
+0.2%
N/A+8.7%£1.09B£189.32M6.00N/ADividend Increase
FSV
Fidelity Investment Trust - Fidelity Special Values
N/AGBX 332.11
+0.2%
N/A+15.6%£1.08B£237.18M4.8325,000Positive News
ASHM
Ashmore Group
1.504 of 5 stars
GBX 158.60
-1.2%
GBX 174
+9.7%
-21.2%£1.06B£199.65M11.24283High Trading Volume
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626Gap Down
BPCR
BioPharma Credit
N/AGBX 0.89
-0.2%
N/A-2.2%£1.05B£12.99B10.09N/APositive News
Remove Ads

Related Companies and Tools


This page (LON:BBH) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners